Published in FEBS Lett on December 29, 2000
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest (2004) 3.63
The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A (2004) 2.39
Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol (2002) 1.18
Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J Clin Biochem Nutr (2010) 1.15
Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J Biol Chem (2013) 1.06
Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediators Inflamm (2001) 1.04
Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem J (2003) 0.90
Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein. FASEB J (2007) 0.88
Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm (2013) 0.87
Fragmentation of extracellular matrix by hypochlorous acid. Biochem J (2003) 0.86
Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100. J Lipid Res (2014) 0.83
Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: glycosylation is required for optimal enzymatic activity. J Biol Chem (2010) 0.82
Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins. Biophys J (2002) 0.81
Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis. PLoS One (2012) 0.81
VPO1 mediates oxidation of LDL and formation of foam cells. Oncotarget (2016) 0.75
Native low density lipoprotein promotes lipid raft formation in macrophages. Mol Med Rep (2016) 0.75
Nuclear microscopy: a novel technique for quantitative imaging of gadolinium distribution within tissue sections. Microsc Microanal (2009) 0.75
Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction. Redox Biol (2017) 0.75
Bilirubin is an antioxidant of possible physiological importance. Science (1987) 11.26
Medicinal plants in Mexico: healers' consensus and cultural importance. Soc Sci Med (1998) 5.51
Treatment of hypertension with ascorbic acid. Lancet (1999) 4.74
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med (1995) 3.60
Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A (1988) 3.42
Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A (1987) 3.35
Biochemistry and pathology of radical-mediated protein oxidation. Biochem J (1997) 3.14
Antioxidants and atherosclerotic heart disease. N Engl J Med (1997) 2.86
Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology (2011) 2.52
Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A (1991) 2.34
Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation (1996) 2.28
Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem (1994) 2.20
Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med (2000) 2.19
High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci U S A (1992) 2.15
The health of smokers' and nonsmokers' children. J Allergy (1969) 2.07
Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest (1996) 2.01
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr (1999) 1.97
Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J (1999) 1.94
Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation (2001) 1.90
Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation (2001) 1.89
Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury. Neurology (2005) 1.76
Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage. Free Radic Biol Med (2001) 1.71
Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol (1994) 1.68
Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2013) 1.61
Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J (1993) 1.55
Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury. Neurology (2010) 1.55
Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem (1998) 1.48
Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J (1998) 1.45
Oxidation of parenteral lipid emulsion by ambient and phototherapy lights: potential toxicity of routine parenteral feeding. J Pediatr (1995) 1.45
Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J (1992) 1.43
Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J (2001) 1.40
Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem (1997) 1.38
Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol Psychiatry (1997) 1.35
Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med (1999) 1.35
Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation (1999) 1.34
Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol (1995) 1.34
Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem J (1994) 1.33
Incidence and clinical pattern of the abdominal compartment syndrome after "damage-control" laparotomy in 311 patients with severe abdominal and/or pelvic trauma. Crit Care Med (2000) 1.32
Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler Thromb Vasc Biol (1995) 1.32
Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol (1998) 1.32
A field study of the effects of elevated CO(2) on plant biomass and community structure in a calcareous grassland. Oecologia (1999) 1.32
Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J Biol Chem (1994) 1.32
Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim Biophys Acta (1992) 1.31
Resource patch formation and exploitation throughout the marine microbial food web. Am Nat (2009) 1.27
Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol (2000) 1.26
Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc Natl Acad Sci U S A (1990) 1.25
Antioxidants in tea. Crit Rev Food Sci Nutr (1997) 1.20
Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res (2000) 1.19
Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein. J Lipid Res (1993) 1.19
Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem (2000) 1.17
ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J Biol Chem (2001) 1.16
Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci U S A (1993) 1.16
Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J (1999) 1.14
Oxidative stress and the redox status of malaria-infected erythrocytes. Blood Cells (1990) 1.14
Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med (1997) 1.13
Radical-induced chain oxidation of proteins and its inhibition by chain-breaking antioxidants. Biochem J (1993) 1.13
Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem (1993) 1.12
Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med (1990) 1.12
Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest (1995) 1.11
Efflux of hepatic ascorbate: a potential contributor to the maintenance of plasma vitamin C. Biochem J (1999) 1.11
Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol (1990) 1.11
Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. J Biol Chem (1998) 1.11
Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep (1999) 1.09
Mechanism of alloxan-induced calcium release from rat liver mitochondria. J Biol Chem (1985) 1.09
Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett (1993) 1.08
Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc Natl Acad Sci U S A (1993) 1.08
Ascorbate: the most effective antioxidant in human blood plasma. Adv Exp Med Biol (1990) 1.07
Increased fluorescence polarization of 1,6-diphenyl-1,3,5-hexatriene in the phorbol myristate acetate-stimulated plasma membrane of human neutrophils. FEBS Lett (1982) 1.07
Ca2+ release from mitochondria induced by prooxidants. Free Radic Biol Med (1988) 1.06
Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A (1994) 1.06
Extubation after breathing trials with automatic tube compensation, T-tube, or pressure support ventilation. Acta Anaesthesiol Scand (2002) 1.06
Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest (1994) 1.06
Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock (1995) 1.06
Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest (1994) 1.06
Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. J Biol Chem (2000) 1.05
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest (1998) 1.05
Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim Biophys Acta (1993) 1.04
Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest trauma. J Trauma (1996) 1.04
Possible mechanisms responsible for the increased ascorbic acid content of Plasmodium vinckei-infected mouse erythrocytes. Biochim Biophys Acta (1986) 1.04
Oxidants and antioxidants in atherosclerosis. Curr Opin Lipidol (2001) 1.04
Is ischemia involved in the pathogenesis of murine cerebral malaria? Am J Pathol (2001) 1.02
Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-gamma-activated human macrophages: posttranslational regulation by pyrrolidine dithiocarbamate. J Immunol (2001) 1.00
Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus. J Gen Virol (1992) 1.00
The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim Biophys Acta (1992) 1.00
The oxidation of blood plasma and low density lipoprotein components by chemically generated singlet oxygen. J Biol Chem (1993) 1.00
Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway. J Clin Invest (1994) 1.00
Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J Lipid Res (1995) 0.99
Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J (2001) 0.99
Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein. J Lipid Res (1995) 0.98
Established acute respiratory distress syndrome: benefit of corticosteroid rescue therapy. Respiration (1998) 0.98
'Spontaneous' genetic damage in man: evaluation of interindividual variability, relationship among markers of damage, and influence of nutritional status. Mutat Res (1997) 0.98
Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. J Biol Chem (1992) 0.98
The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic Biol Med (2000) 0.98
Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J Biol Chem (1995) 0.97
Cholesterylester hydroperoxide reducing activity associated with isolated high- and low-density lipoproteins. Free Radic Biol Med (1995) 0.97
Breathing pattern and additional work of breathing in spontaneously breathing patients with different ventilatory demands during inspiratory pressure support and automatic tube compensation. Intensive Care Med (1997) 0.97
Menadione- (2-methyl-1,4-naphthoquinone-) dependent enzymatic redox cycling and calcium release by mitochondria. Biochemistry (1986) 0.97